2026年04月02日 / ライフスタイル

Obesity Treatment Cannot Rely Solely on "Medication" — Pharmacists as Companions Filling the Blind Spots in Obesity Support

Obesity Treatment Cannot Rely Solely on "Medication" — Pharmacists as Companions Filling the Blind Spots in Obesity Support

Why is Obesity Treatment So Difficult to Maintain?

When discussing obesity treatment, the narrative often still revolves around oversimplifications like "overeating," "lack of exercise," and "personal willpower." However, in reality, obesity is increasingly being treated as a chronic disease that involves not only lifestyle habits but also psychological factors, social isolation, sleep, comorbidities, medication status, and economic conditions. The French government's roadmap for 2026-2030 also aims to structure support for obesity, strengthen collaboration among professionals, and reduce regional disparities. The HAS (French National Authority for Health) emphasizes early detection, individualization, multidisciplinary evaluation, and addressing stigma.

The Argument of "Proximity of Pharmacists"

The core of the article from the French pharmacy specialist media suggests that the "proximity" of pharmacists could be significant in dealing with long-term, complex diseases like obesity, which are prone to patient dropout. From the search snippet, it is evident that 97% of survey respondents believe pharmacists can play a role in obesity care, and there is an awareness that obesity often accompanies many chronic diseases. This aligns with the movement to reevaluate pharmacists not just as "dispensers of medication" but as supporters of patients at critical points in the treatment pathway.

Pharmacists' Strength Lies More in "Frequent Contact" than Expertise

Why pharmacists? The reason is simple: they are one of the most accessible healthcare professionals for patients. As of January 2025, there are 75,080 registered pharmacists in France, with 20,242 pharmacies. Their presence as a network supporting regional healthcare access remains significant. For conditions like obesity, which require support over months or years, the sheer number of contact points—being "always available for consultation," "meeting before and after doctor visits," and "being able to express side effects and concerns early"—becomes valuable.

Moreover, Obesity Cannot Be Tracked by Numbers Alone

The HAS guidelines emphasize that BMI and waist circumference alone are not sufficient. What is needed is a multifaceted evaluation that includes disordered eating behaviors, psychological difficulties, social vulnerabilities, stigma, and lifestyle background. Furthermore, complex obesity requires long-term, sometimes lifelong, follow-up. It is important to note that patients cannot always bring "heavy consultations" to specialized hospitals. Minor setbacks, doubts about medication, changes in physical condition, and unspoken anxieties—whether these subtle signs can be detected or not affects the continuation rate. Pharmacies are well-positioned to spot these initial signs.

In the Era of GLP-1, the Role of Pharmacies Becomes Even More Important

There is often high anticipation surrounding obesity medications, especially GLP-1 agonists. However, the ANSM advises against using these drugs for cosmetic weight loss and positions them as second-choice medications after nutritional and exercise interventions have failed, repeatedly calling for their proper use. In the 2026 safety information, the possibility of nutritional deficiencies among serious side effects is indicated, and the risks associated with rapid weight loss continue to be monitored. Therefore, even in an era where medication is available, support beyond medication is necessary. Confirming medication adherence, listening for side effects, encouraging medical visits, and preventing self-discontinuation—these are tasks that pharmacies are well-suited to handle.

However, Pharmacists Cannot Do Everything

This should not be misunderstood. The diagnosis of obesity, determination of treatment plans, and decisions regarding pharmacotherapy or surgery are fundamentally the work of a multidisciplinary team centered around physicians. The HAS also designs obesity care to be shared across multiple professions and domains, and by 2026, a "reinforced collaborative care pathway" for complex adult obesity became eligible for insurance coverage. What is required is not to "pass the buck" to pharmacists but to integrate them as the entry and continuous contact point in the community. The essence is to reduce the moments when patients become unreachable by doctors, dietitians, psychologists, exercise instructors, and specialized centers.

On Social Media, "Rejection of Personal Responsibility" and "Safety Concerns" Stood Out

Looking at public social media posts, reactions to this theme are largely divided into three categories. First, there is a shared recognition that "obesity is not a lack of willpower." A LinkedIn post from the pharmacy network APRIUM reinterprets obesity as "accompanying rather than guilt," explaining that its causes are multifactorial, including biological, hormonal, psychological, environmental, and social factors. Second, there is an expectation of pharmacies and pharmacists. A post from USPO highlights that obesity significantly impacts healthcare finances and, due to its complexity, requires a holistic response. Third, there is caution regarding safety. On LinkedIn, there are warnings about obesity medications sold online and concerns about counterfeit and improper use. ANSM's posts on X emphasize that pharmacotherapy should be conducted according to care pathways.

What Emerges Here is a Change in What Patients Are Seeking

Summarizing the social media reactions, what patients and surrounding healthcare providers are seeking is not just "stronger medication." Rather, they want to be able to talk without shame, not drop out midway, receive practical advice when overwhelmed with too much information, and be stopped from dangerous acquisition routes and self-use. Obesity care is becoming more sophisticated medically, yet practically requires more "support close to daily life." As a place to fill that contradiction, pharmacies hold a very rational position.

This is Not Just a Foreign Issue for Japan

The reason this French article resonates with Japanese readers is that the same challenges exist. Obesity is difficult to resolve through numerical management alone, requiring encouragement for medical visits, medication follow-up, continued lifestyle improvement, stigma reduction, and bridging to specialized medical care. And these cannot be completed solely within hospitals. Whether patients can be picked up at the stage where they are "concerned but not to the extent of visiting a hospital" is where the role of community pharmacies lies. The important thing is not to elevate pharmacists as omnipotent healers. It is whether they can function as "translators" who accompany patients closely so they do not fall through the cracks of treatment. The French discussion frankly demonstrates this reality.


List of Source URLs